We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Viral Transport Medium Market Driven by Increasing Prevalence of Infectious Diseases

By LabMedica International staff writers
Posted on 25 Aug 2022
Print article
Image: The global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027 (Photo courtesy of Pexels)
Image: The global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027 (Photo courtesy of Pexels)

Viral transport medium (VTM) assumed importance globally when the new H1N1 influenza virus was identified, causing the world's first flu pandemic in more than 40 years. Since then, it has been used majorly by hospitals, labs, and academic/research institutes for transporting viral samples across the research and clinical value chain. During the transport, the virus, if present, in the sample specimen should remain intact until the testing is completed. More recently, the sudden onset of the COVID-19 pandemic significantly boosted the demand for transport medium products and related kits. With the fast spread of the COVID-19 virus, many countries prioritized diagnostic testing for quick diagnosis of the virus, fuelling an exponential increase in the demand for VTM kits for sample collection from suspected COVID-19 patients. Other viral infections, such as influenza, herpes, varicella, respiratory syncytial virus, and viral infectious diseases, also demand quick diagnosis in which VTM kits play a vital role in the collection, preservation, and transportation of specimens. As a result, the global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027, driven by the increasing prevalence of infectious diseases.

These are the latest findings of Research and Markets (Dublin, Ireland), the world’s largest market research store.

VTM kits are constantly in demand due to the increasing prevalence of infectious diseases. The rising prevalence of viral infectious diseases has fueled an increase in the use of VTM kits. Some of the viral infectious diseases are COVID-19, influenza virus, enterovirus D68, herpes, varicella, RSV, etc. For diagnosing these diseases, the collection of samples, preservation, and transportation is required, with VTM kits being the most prominently used solutions by practitioners.

The demand for viral transport increased exponentially during the COVID-19 pandemic. The rise in COVID-19 testing across the world led to an increase in the consumption rate of VTM test kits. Millions of COVID-19 tests were done daily from June 2020 to January 2022, which proved to be a major turning point for the VTM market. With academic/research institutes intensifying their experiments for developing vaccines and mass testing to stop the spread of COVID-19 globally, vendors also increased their manufacturing capacities and produced billions of VTM kits. The companies have been focusing on innovation and developing kits containing double-ended flocked swabs, vials, antibiotics, and other items that inhibit microbial contamination.

In addition, with the continuous increase in seasonal flu cases, manufacturers are also manufacturing viral transport for influenza tests, owing to influenza-related morbidity and mortality in many countries. Efforts to improve the diagnostic rate and accuracy of viral infectious diseases continue to drive the VTM market growth as this requires laboratory testing of clinical specimens to identify the virus, viral antigens, and antibodies. In addition, a rapid increase in the aging population, rise in the number of people undergoing various voluntary surgeries and other factors have also accelerated the requirement for various diagnostic tests that involve the use of VTM kits.

Geographically, North America accounts for the largest share of the global VTM market due to a high number of laboratory tests conducted during the pandemic, presence of biopharma companies, large number of laboratories, well-developed healthcare services, and research studies carried out in the region. Influenza viral infections continue to increase in the African, North America, and Asia Pacific regions, which will require quick diagnosis and the need for collection, preservation, and transportation of specimens, thereby driving the growth of the global VTM market.

 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.